ThINKK Adoptive Immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ThINKK Adoptive Immunotherapy, covering 2026-04-08 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma [Phase 1]